Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aytu Biopharma Inc
(NQ:
AYTU
)
1.630
+0.120 (+7.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 02, 2023
Via
Benzinga
Why BlackBerry Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
May 02, 2023
Gainers Leju Holdings Limited (NYSE: LEJU) gained 103.7% to $7.25 in pre-market trading after jumping around 97% on Monday .
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 02, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer
April 27, 2023
Via
ACCESSWIRE
Aytu BioPharma's Return On Capital Employed Insights
February 22, 2023
Via
Benzinga
Aytu BioPharma Reports Second Quarter of Fiscal Year 2023
February 21, 2023
Via
ACCESSWIRE
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
May 01, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 27, 2023
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023
February 21, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Delayed Filing of Second Quarter Fiscal 2023 Financial Results
February 14, 2023
Via
ACCESSWIRE
Earnings Preview For Aytu BioPharma
February 13, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Second Year in a Row
November 17, 2022
Via
ACCESSWIRE
Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023
November 14, 2022
Via
ACCESSWIRE
Earnings Scheduled For February 14, 2023
February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
February 07, 2023
Via
ACCESSWIRE
Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance
January 25, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31
January 24, 2023
Via
ACCESSWIRE
Aytu BioPharma, Inc Continues Availability of Adzenys XR-ODT(R) as the Only FDA-Approved Orally Disintegrating Tablet (ODT) Medication that is Bioequivalent to Adderall XR(R) for ADHD Patients
January 10, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via
Benzinga
Aytu BioPharma Announces 1-for-20 Reverse Stock Split
January 05, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
December 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Muscle Maker And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
December 22, 2022
The Dow Jones settled higher by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect
November 30, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 23, 2022
Via
Benzinga
Aytu BioPharma Receives a 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
November 22, 2022
Via
ACCESSWIRE
Aytu BioPharma Announces the Passing of Co-Founder and Board Member Michael Macaluso
November 16, 2022
Via
ACCESSWIRE
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
November 09, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.